Daniel Markowitz
Stock Analyst at Evercore ISI Group
(1.71)
# 3,310
Out of 4,966 analysts
6
Total ratings
50%
Success rate
1.56%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Initiates: Outperform | $170 | $167.88 | +1.26% | 1 | Jul 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $275 → $350 | $245.45 | +42.60% | 2 | Jul 25, 2025 | |
| RGEN Repligen | Maintains: In-Line | $140 → $130 | $122.17 | +6.41% | 2 | Jul 8, 2025 | |
| TECH Bio-Techne | Initiates: Outperform | $75 | $54.33 | +38.05% | 1 | Mar 18, 2025 |
Natera
Jul 28, 2025
Initiates: Outperform
Price Target: $170
Current: $167.88
Upside: +1.26%
West Pharmaceutical Services
Jul 25, 2025
Maintains: Outperform
Price Target: $275 → $350
Current: $245.45
Upside: +42.60%
Repligen
Jul 8, 2025
Maintains: In-Line
Price Target: $140 → $130
Current: $122.17
Upside: +6.41%
Bio-Techne
Mar 18, 2025
Initiates: Outperform
Price Target: $75
Current: $54.33
Upside: +38.05%